Rocket One RKTO
NASDAQ RKTO
$0.67 -0.02 (-3.29%)
As of: Sep 9, 2026 · 3:33 PM EDT

Rocket One (RKTO) Restructuring Costs (2023 - 2024)

Rocket One's (RKTO) quarterly Restructuring Costs came in at $326880.0 in Q1 2024, down 41.61% quarter-over-quarter from $559848.0 in Q4 2023.

Analysis

Rocket One (RKTO) Restructuring Costs (2023 - 2024) Analysis & Trends

Rocket One has disclosed Restructuring Costs across 2 years of filings, most recently posting $326880.0 for Q1 2024.

  • In Q1 2024, Restructuring Costs changed N/A year-over-year to $326880.0; the TTM figure through Mar 2024 stood at $1.0 million (changed N/A YoY), while the FY2023 annual figure was $1.0 million, changed N/A from the prior year.
  • Restructuring Costs came in at $326880.0 for Q1 2024 at Rocket One, down from $559848.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $559848.0 in Q4 2023 to a low of $46171.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 212.04 Bn 198.05 Bn 7.24 Bn
2 Gilead Sciences 181.35 Bn 178.17 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.22 Bn 124.37 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.94 Bn 74.94 Bn 3.93 Bn
5 Argenx Se 61.53 Bn 56.34 Bn 1.37 Bn
6 Moderna 54.25 Bn 49.11 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.41 Bn 31.10 Bn 992.69 Mn
8 Biogen 31.19 Bn 29.91 Bn 1.96 Bn
9 Roivant Sciences 30.10 Bn 30.10 Bn 1.16 Mn
10 Rocket One 13.87 Mn 5.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 326,880.00
Dec 31, 2023 559,848.00
Sep 30, 2023 67,101.00
Jun 30, 2023 46,171.00